BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2026 9:45:08 AM | Browse: 2 | Download: 0
 |
Received |
|
2026-02-13 02:03 |
|
Peer-Review Started |
|
2026-02-13 02:04 |
|
First Decision by Editorial Office Director |
|
2026-02-25 03:18 |
|
Return for Revision |
|
2026-02-25 03:18 |
|
Revised |
|
2026-03-02 03:35 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-04-13 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-04-13 09:24 |
|
Articles in Press |
|
2026-04-13 09:24 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-08 06:51 |
|
Publish the Manuscript Online |
|
2026-09-09 09:45 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Programmed death-1/programmed death-ligand 1 inhibitors in the treatment of elderly patients with advanced pancreatic cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yan Feng, Hai-Wei Yu and Ke Xu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ke Xu, MD, Department of Oncology, The First Affiliated Hospital of Chengdu Medical College, No. 278 Baoguang Street, Xindu District, Chengdu 610500, Sichuan Province, China. xuke@cmc.edu.cn |
| Key Words |
Elderly; Advanced pancreatic cancer; Programmed death-1 inhibitors; Prognosis; Safety |
| Core Tip |
The recent study by Lu et al identified Eastern Cooperative Oncology Group performance status, prognostic nutritional index, and triglyceride levels as independent predictors for progression-free survival and overall survival in elderly patients with advanced pancreatic cancer receiving programmed death-1 inhibitors. While the results still need further verification, this work provides important clues in this underexplored research domain. |
| Publish Date |
2026-09-09 09:45 |
| Citation |
Feng Y, Yu HW, Xu K. Letter to the Editor: Programmed death-1/programmed death-ligand 1 inhibitors in the treatment of elderly patients with advanced pancreatic cancer. World J Gastrointest Oncol 2026; 18(9): 120033
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i9/120033.htm |
| DOI |
https://doi.org/10.4251/wjgo.120033 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
